Back
Enanta Pharmaceuticals Vs. Aritzia Industry Stock Comparison
Sell
32
ENTA
Enanta Pharmaceuticals
Last Price:
10.31
Seasonality Move:
17.72%
Sell
40
ATZAF
Aritzia
Last Price:
32.69
Seasonality Move:
14.48%
Sell
32
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $10.44. The Score for ENTA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Aritzia (ATZAF)
is a Sell
Is Aritzia a Buy, Sell or Hold?
- The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $10.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
ATZAF Stock Price Chart
ENTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 35.05 | Sell |
| Chaikin Money Flow: | -60073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.81 - 12.19) | Sell |
| Bollinger Bands (100): | (11.05 - 14.03) | Sell |
ATZAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 51.58 | Buy |
| Chaikin Money Flow: | 485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.46 - 34.6) | Buy |
| Bollinger Bands (100): | (30.22 - 35.52) | Buy |
ENTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.04 | Sell |
| 20-day SMA: | 11.6 | Sell |
| 50-day SMA: | 11.43 | Sell |
| 200-day SMA: | 13.13 | Sell |
| 8-day EMA: | 10.95 | Sell |
| 20-day EMA: | 11.26 | Sell |
| 50-day EMA: | 11.63 | Sell |
| 200-day EMA: | 13.36 | Sell |
ATZAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.85 | Buy |
| 20-day SMA: | 31.82 | Buy |
| 50-day SMA: | 34.06 | Sell |
| 200-day SMA: | 29.54 | Buy |
| 8-day EMA: | 31.74 | Buy |
| 20-day EMA: | 32.3 | Buy |
| 50-day EMA: | 33.02 | Buy |
| 200-day EMA: | 30 | Buy |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.
Aritzia Earnings Growth & ATZAF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.
Enanta Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aritzia Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||